🏆 which
Which vaccine is most associated with preventing severe disease from respiratory syncytial virus in older adults?
MedicineVaccines
Quick Answer
New RSV vaccines for older adults are the main modern vaccines associated with preventing severe respiratory syncytial virus disease in this age group. Several were authorized in 2023.
The Full Story
Respiratory syncytial virus, or RSV, is a major cause of severe respiratory illness in infants and older adults. In 2023, the first RSV vaccines for older adults were authorized in several countries, marking a major advance after decades without a licensed vaccine. These vaccines are designed to reduce severe lower respiratory tract disease and hospitalizations. Their arrival filled a long-standing gap in adult immunization.
Key Facts
1.First older-adult RSV vaccines authorized in 2023
2.Targets severe lower respiratory disease
3.RSV is a major cause of hospitalization in seniors
YouTube Angle
Suggested video title for this topic:
"After decades of waiting, the RSV vaccine finally arrived for older adults."